United States · FDA National Drug Code directory
ciprofloxacin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 54348-662_ea938405-8d24-fa08-e053-2995a90af8dc
- Product NDC
- 54348-662
- Form
- TABLET
- Composition / generic term
- CIPROFLOXACIN
- Labeler
- PharmPak, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190710
- Source listing expiry
- 20261231
Source-listed ingredients
- CIPROFLOXACIN HYDROCHLORIDE — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 BOX (54348-662-06) / 6 TABLET in 1 BOTTLE · 54348-662-06
- 1 BOTTLE in 1 BOX (54348-662-14) / 14 TABLET in 1 BOTTLE · 54348-662-14
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →